Symbol="CHRS"
AssetType="Common Stock"
Name="Coherus BioSciences Inc"
Description="Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California."
CIK="1512762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="399017000"
EBITDA="-234919008"
PERatio="None"
PEGRatio="0"
BookValue="-2.441"
DividendPerShare="0"
DividendYield="0"
EPS="-3.31"
RevenuePerShareTTM="2.347"
ProfitMargin="-1.48"
OperatingMarginTTM="-1.302"
ReturnOnAssetsTTM="-0.3"
ReturnOnEquityTTM="-16.57"
RevenueTTM="183363000"
GrossProfitTTM="-58399000"
DilutedEPSTTM="-3.31"
QuarterlyEarningsGrowthYOY="-0.755"
QuarterlyRevenueGrowthYOY="-0.46"
AnalystTargetPrice="14"
TrailingPE="-"
ForwardPE="32.89"
PriceToSalesRatioTTM="2.354"
PriceToBookRatio="73.19"
EVToRevenue="3.202"
EVToEBITDA="-3.109"
Beta="0.887"
num_52WeekHigh="14.11"
num_52WeekLow="3.6"
num_50DayMovingAverage="4.621"
num_200DayMovingAverage="6.95"
SharesOutstanding="94442000"
DividendDate="None"
ExDividendDate="None"
symbol="CHRS"
open="4.19"
high="4.40"
low="4.12"
price="4.29"
volume="1549580.00"
latest_trading_day="2023-07-21"
previous_close="4.17"
change="0.12"
change_percent="2.8777%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="75"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="25"
Volume_recent_avg="2573936"
Change_recent_avg="-0.03"
Delta_recent_avg="0.42"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="-0.77"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="25"
Aroon_momentum_negative="75"
image_negative_thumbnail_id_1="128"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0048.jpeg"
image_negative_thumbnail_id_2="1120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="642"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_positive_thumbnail_id_2="989"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
